News

Article

PTSM: Pharmaceutical Technology Sourcing and Management

PTSM: Pharmaceutical Technology Sourcing and Management

PTSM: Pharmaceutical Technology Sourcing and Management-09-07-2016
Volume11
Issue 9

PANalytical launches the Empyrean Nano edition

The Empyrean Nano edition offers a combination of advanced X-ray scattering techniques.

PANalytical launched the Empyrean Nano edition in August 2016, a new hybrid laboratory instrument that offers a combination of advanced X-ray scattering techniques. From the experimental data, (nano)material researchers can deduce information about nanoscale structures, dimensions, in addition to order and disorder on the atomic level.

The Empyrean Nano edition supports all major elastic X-ray scattering techniques, namely ultra-small-angle X-ray scattering, small- and wide-angle X-ray scattering, SAXS on biological macromolecules, and total scattering. The instrument includes a high-resolution goniometer, a modular concept based on pre-aligned components, and detector technology. Empyrean Nano edition has the ability to characterize nanoparticles, colloids, protein solutions, surfactants, porous materials, polymers, nanocomposites, liquid crystals, and glasses.

Source: PANalytical 

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
A global supply chain map, visualizing the complex network of transportation routes and distribution centers | Image Credit: © venusvi - stock.adobe.com
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Jason Waite, International Trade Expert, Alston & Bird
Simona Guidi, Associate Director, ProPharma
Tore Bergsteiner
Behind the Headlines, Episode 20: CAR-T Milestones, Abbvie and Eli Lilly M&A Moves, and More
Related Content